- Home
- RCUS vs TLRY Comparison
RCUS vs TLRY Comparison
Compare RCUS & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- TLRY
- Stock Information
- Founded
- RCUS 2015
- TLRY N/A
- Country
- RCUS United States
- TLRY Canada
- Employees
- RCUS N/A
- TLRY N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- RCUS Health Care
- TLRY Health Care
- Exchange
- RCUS Nasdaq
- TLRY Nasdaq
- Market Cap
- RCUS 727.1M
- TLRY 637.2M
- IPO Year
- RCUS 2018
- TLRY 2018
- Fundamental
- Price
- RCUS $7.88
- TLRY $0.45
- Analyst Decision
- RCUS Strong Buy
- TLRY Hold
- Analyst Count
- RCUS 10
- TLRY 4
- Target Price
- RCUS $29.50
- TLRY $1.58
- AVG Volume (30 Days)
- RCUS 1.2M
- TLRY 26.1M
- Earning Date
- RCUS 05-07-2025
- TLRY 04-08-2025
- Dividend Yield
- RCUS N/A
- TLRY N/A
- EPS Growth
- RCUS N/A
- TLRY N/A
- EPS
- RCUS N/A
- TLRY N/A
- Revenue
- RCUS $258,000,000.00
- TLRY $826,656,000.00
- Revenue This Year
- RCUS N/A
- TLRY $11.80
- Revenue Next Year
- RCUS $25.77
- TLRY $5.41
- P/E Ratio
- RCUS N/A
- TLRY N/A
- Revenue Growth
- RCUS 120.51
- TLRY 11.22
- 52 Week Low
- RCUS $6.50
- TLRY $0.43
- 52 Week High
- RCUS $18.98
- TLRY $2.52
- Technical
- Relative Strength Index (RSI)
- RCUS 44.26
- TLRY 29.90
- Support Level
- RCUS $6.75
- TLRY $0.46
- Resistance Level
- RCUS $8.36
- TLRY $0.52
- Average True Range (ATR)
- RCUS 0.60
- TLRY 0.05
- MACD
- RCUS 0.16
- TLRY -0.01
- Stochastic Oscillator
- RCUS 74.19
- TLRY 8.33
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.